IL-21 enhances rituximab-mediated killing of B-lymphoma cell lines in vitro and in vivo
Wayne Kindsvogel, Donald M. Foster, Elisabeth Sievers(Karolinska University Hospital), Christopher H. Clegg(TRIA Bioscience (United States)), Mark Heipel, S. Hughes, Rick D. Holly, Pallavur V. Sivakumar, K. Bannink, B. Johnson
Cited by 5
Related Papers
Human Cytomegalovirus Glycoprotein UL16 Causes Intracellular Sequestration of NKG2D Ligands, Protecting Against Natural Killer Cell Cytotoxicity
|The Journal of Experimental Medicine|2003|283
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
|Clinical Cancer Research|2016|113
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma
|Oncogene|2013|95
Activated γδ T cells express the natural cytotoxicity receptor natural killer p44 and show cytotoxic activity against myeloma cells
|Clinical & Experimental Immunology|2006|90